Description
Elvitegravir is an antiviral compound that inhibits integrase activity. This compound is clinically used to treat HIV infection.
Product Unit Size | Cost | Quantity | Stock |
---|
Elvitegravir is an antiviral compound that inhibits integrase activity. This compound is clinically used to treat HIV infection.
Cas No. | 697761-98-1 |
---|---|
Purity | ≥98% |
Formula | C23H23ClFNO5 |
Formula Wt. | 447.88 |
IUPAC Name | 6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid |
Synonym | GS-9137, JTK-303 |
Solubility | DMSO 89 mg/mL (198.71 mM) Ethanol 35 mg/mL (78.14 mM) Water Insoluble |
Appearance | White to off white powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Reviriego C. Elvitegravir for the treatment of HIV infection. Drugs Today (Barc). 2014 Mar;50(3):209-17. PMID: 24696866.
Shimura K, Kodama E, Sakagami Y, et al. Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137). J Virol. 2008 Jan;82(2):764-74. PMID: 17977962.
TRPC5, NS4B, histamine H1 inhibitor.
Synephrine is an endogenous alkaloid.
Glucocorticoid
Retinoid; RARα/β/γ agonist.
BHA derivative, antioxidative food and cosmetic...
Cathelicidin derivative, antimicrobial peptide,...
HIV and AIDS
Aldosterone antagonist.
NMDA NR1/NR2B antagonist.
Calcium channel blocker.
TRPA1 antagonist
Peptide; NMDA partial agonist.
Polypeptide; peptidoglycan inhibitor.
ACE inhibitor.
AhR antagonist.
Isocitrate dehydrogenase inhibitor.
MEK inhibitor.
BCL-XL specific degrader
NSAID; COX-1/2 inhibitor.
Trichothecene mycotoxin produced by Fusarium.